A.R.T. Advisors’s Windtree Therapeutics Inc WINT Stock Holding History
Bought
Maintained
Sold
Other funds holding WINT
A.R.T. Advisors's WINT Position: Q2 2017 in Review
A.R.T. Advisors sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 14,300 shares — an estimated $16K sold.
A.R.T. Advisors first reported a position in WINT in Q4 2016 and held it in 2 quarters. The position peaked at $20K in Q4 2016. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.
- A.R.T. Advisors reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
- A.R.T. Advisors sold 14,300 Windtree Therapeutics Inc shares in Q2 2017, an estimated $16K.
- A.R.T. Advisors first reported a position in Windtree Therapeutics Inc in Q4 2016 and held it in 2 quarters.
- A.R.T. Advisors's Windtree Therapeutics Inc position peaked at $20K in Q4 2016.
- 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.
Based on A.R.T. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.